| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 16 |
| 1 | APREMILAST | 3 |
| 2 | DUPILUMAB | 3 |
| 3 | ATEZOLIZUMAB | 2 |
| 4 | CYCLOSPORINE | 2 |
| 5 | INFLIXIMAB | 2 |
| 6 | LIFITEGRAST | 2 |
| 7 | NIVOLUMAB | 2 |
| 8 | RISANKIZUMAB-RZAA | 2 |
| 9 | TIRZEPATIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLUENZA A VIRUS, INFLUENZA B VIRUS, HISTAMINUM HYDROCHLORICUM, ACONITUM NAP., ARALIA QUINQUEFOLIA, ARSENICUM ALB., BAPTISIA, BRYONIA, CINCHONA, EUPATORIUM PERF., GELSEMIUM, IPECAC., KALI CARB., NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, ECHINACEA | 1 | 0.0029 |
| 1 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 2 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 3 | GLUTATHIONE | 1 | 0.0006 |
| 4 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| 6 | BROLUCIZUMAB | 1 | 0.0003 |
| 7 | CROMOLYN SODIUM | 1 | 0.0003 |
| 8 | AVELUMAB | 1 | 0.0002 |
| 9 | LIFITEGRAST | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 1 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |
| 2 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |